Category: News
Atuka moves into North America’s largest urban innovation hub
In a significant moment for Atuka, we have completed the move into our new offices and facilities in the MaRS Discovery District in Toronto.
Atuka releases its latest white paper, on the future of gene therapy
Building on Atuka’s pioneering work in Parkinson’s disease and other neurodegenerative disorders, this paper lays out the transformative potential of gene therapy.
Announcing a $1.5m collaboration with Kannalife Sciences and Michael J. Fox Foundation
The grant will fund preclinical research of Kannalife Science’s KLS-13019, a synthetic cannabinoid therapeutic which offers great promise for Parkinson’s disease.
Atuka welcomes new board member Ian Lennox
As Atuka expands beyond its traditional base in Parkinson’s research, we look forward to Lennox’s contributions as a pioneering executive with decades of experience as an innovator in our sector.